Magellan Health Reports Fourth Quarter and Full Year 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Jefferies Reiterates Buy on Magellan Health (MGLN) Following 4Q - PT to $77
March 1, 2016 9:35 AM ESTJefferies reiterated a Buy rating on Magellan Health Services (NASDAQ: MGLN), and raised the price target to $77.00 (from $73.00), following the company's 4Q.
Analyst David Styblo commented, "We still believe MGLN is undervalued despite today's surge (+8% vs S&P's -0.3%). The Healthcare and Pharmacy Solution... More
